BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 38667320)

  • 1. Dysfunction of Small-Conductance Ca
    Yakhnitsa V; Thompson J; Ponomareva O; Ji G; Kiritoshi T; Mahimainathan L; Molehin D; Pruitt K; Neugebauer V
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa Opioid Receptor Distribution and Function in Primary Afferents.
    Snyder LM; Chiang MC; Loeza-Alcocer E; Omori Y; Hachisuka J; Sheahan TD; Gale JR; Adelman PC; Sypek EI; Fulton SA; Friedman RL; Wright MC; Duque MG; Lee YS; Hu Z; Huang H; Cai X; Meerschaert KA; Nagarajan V; Hirai T; Scherrer G; Kaplan DH; Porreca F; Davis BM; Gold MS; Koerber HR; Ross SE
    Neuron; 2018 Sep; 99(6):1274-1288.e6. PubMed ID: 30236284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of DREADD agonists and administration route in a murine model of sleep enhancement.
    Ferrari LL; Ogbeide-Latario OE; Gompf HS; Anaclet C
    J Neurosci Methods; 2022 Oct; 380():109679. PubMed ID: 35914577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a 3-D computational model of neurons in the central amygdala to understand pharmacological targets for pain.
    Miller Neilan R; Reith C; Anandan I; Kraeuter K; Allen HN; Kolber BJ
    Front Pain Res (Lausanne); 2023; 4():1183553. PubMed ID: 37332477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders.
    Limoges A; Yarur HE; Tejeda HA
    Front Syst Neurosci; 2022; 16():963691. PubMed ID: 36276608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical review of effects on ethanol intake of the dynorphin/kappa opioid receptor system in the extended amygdala: From inhibition to stimulation.
    Pirino BE; Kelley AM; Karkhanis AN; Barson JR
    Alcohol Clin Exp Res (Hoboken); 2023 Jun; 47(6):1027-1038. PubMed ID: 37042026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemogenetic Manipulation of Amygdala Kappa Opioid Receptor Neurons Modulates Amygdala Neuronal Activity and Neuropathic Pain Behaviors.
    Ji G; Presto P; Kiritoshi T; Chen Y; Navratilova E; Porreca F; Neugebauer V
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain.
    Navratilova E; Ji G; Phelps C; Qu C; Hein M; Yakhnitsa V; Neugebauer V; Porreca F
    Pain; 2019 Apr; 160(4):824-832. PubMed ID: 30681985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice.
    Anderson RI; Lopez MF; Griffin WC; Haun HL; Bloodgood DW; Pati D; Boyt KM; Kash TL; Becker HC
    Neuropsychopharmacology; 2019 May; 44(6):1084-1092. PubMed ID: 30555162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors.
    Hein M; Ji G; Tidwell D; D'Souza P; Kiritoshi T; Yakhnitsa V; Navratilova E; Porreca F; Neugebauer V
    Neuropharmacology; 2021 Mar; 185():108456. PubMed ID: 33444637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioid receptors in the central amygdala modulate spinal nociceptive processing through an action on amygdala CRF neurons.
    Ji G; Neugebauer V
    Mol Brain; 2020 Sep; 13(1):128. PubMed ID: 32948219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
    J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deschloroclozapine exhibits an exquisite agonistic effect at lower concentration compared to clozapine-N-oxide in hM3Dq expressing chemogenetically modified rats.
    Shimizu M; Yoshimura M; Baba K; Ikeda N; Nonaka Y; Maruyama T; Onaka T; Ueta Y
    Front Neurosci; 2023; 17():1301515. PubMed ID: 38099201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing Effects on Descending Control of Nociception by µ and κ Opioid Receptors in the Anterior Cingulate Cortex.
    Navratilova E; Qu C; Ji G; Neugebauer V; Guerrero M; Rosen H; Roberts E; Porreca F
    Anesthesiology; 2024 Feb; 140(2):272-283. PubMed ID: 37725756
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.